Suven Life Sciences Shares
- All
- News
-
Suven Life Sciences Surges On Announcing Phase 3 Trial For Alzheimer's Drug
Shares of drug maker Suven Life Sciences rose as much as 10.65 per cent to hit an intraday high of Rs 87.80.
-
Suven Life Shares Rise As Firm Gets Patents For Neuro-Degenerative Drug
Suven Life Sciences shares were trading 5.36 per cent up at Rs 166 on BSE in the morning trade.
-
Suven Life Gets Patent For Neuro-Degenerative Drug
With the new patents, Suven has a total of 20 granted patent from Eurasia and 6 from Norway.
-
Suven Life Surges On Getting Patent For Neuro Degenerative Drug
Shares of Suven Life Sciences rose over 5 per cent today as the company has been granted one product patent each by Europe and Israel for a drug used in the treatment of neuro-degenerative diseases.
-
Suven Gets 2 Patents For Molecules Targeting CNS Disorder
The products are useful in the treatment of cognitive impairment associated with neuro-degenerative disorders like Alzheimer's disease, attention-deficient hyperactivity disorder, Huntington's disease, major depressive disorder, Parkinson's and schizophrenia, Suven Life Sciences said.
-
Suven Life Receives Establishment Inspection Report From USFDA
Drug firm Suven Life Sciences said it has received the Establishment Inspection Report (EIR) from the US health regulator for its manufacturing plant near Hyderabad.
-
Suven Life Up Over 3% On Patent For Neuro-Degenerative Drug
Suven Life said it has been granted "one product patent from Europe and two product patents from Eurasia corresponding to New Chemical Entities (NCEs) for treatment of disorders associated with neuro-degenerative diseases".
-
Suven Life Gets Patents For Neuro-Degenerative Drug
Drug firm Suven Life Sciences has been granted a patent each by Australia, Eurasia, Israel and the US for a drug used in treatment of neuro-degenerative diseases.
-
Suven Life Gets Patent for Neuro-Degenerative Drug, Shares Rise
Suven Life Sciences has been granted a patent each by China, Eurasia and Hong Kong for a drug used in the treatment of neuro-degenerative diseases.
-
Suven Life Sciences Gets Patent Rights For 2 Drugs; Shares Rally 5%
Suven Life Sciences shares rallied as much as 5 per cent to hit intra-day high of Rs 275.20, after the company declared it had received patent rights from Europe and Macau for two drugs used in the treatment of disorders associated with neurodegenerative diseases.
-
Suven Life Gets Patent for Neuro-Degenerative Drug
Suven Life Sciences has been granted a patent each by Europe, Hong Kong, Japan, Macau, the African Regional Intellectual Property Organisationand South Korea for a drug used in the treatment of neuro-degenerative diseases.
-
Suven Life Sciences Gets Product Patents for CNS Molecule
Products out of these inventions may be out-licenced at various phases of clinical development like at Phase-I or Phase-II, Suven said.
-
Suven Life Gets Patents for Neurodegenerative Drug
Biopharma firm Suven Life Sciences on Wednesday said it has been granted two patents from Canada and one in China for a drug used in the treatment of neurodegenerative diseases.
-
Suven Life Gets Patent for Neuro-Degenerative Disease-Related Products
Drug firm Suven Life Sciences has been granted patents by China, South Africa and Mexico for new chemical molecules that can be used in drugs for treating neuro-degenerative diseases.
-
Suven Life Sciences allots equity shares
Under ESOPThe committee of Suven Life Sciences on 05 May 2010 has allotted 6,61,848 equity shares under stock option plans of the company.Further, consequent to the above allotment, the paid up share capital of the company has gone up from 115874400 equity shares of Re 1 each, aggregating to Rs. 11.59 crore to 116536248 equity shares of Re 1 each, ...
-
Suven Life Sciences Surges On Announcing Phase 3 Trial For Alzheimer's Drug
Shares of drug maker Suven Life Sciences rose as much as 10.65 per cent to hit an intraday high of Rs 87.80.
-
Suven Life Shares Rise As Firm Gets Patents For Neuro-Degenerative Drug
Suven Life Sciences shares were trading 5.36 per cent up at Rs 166 on BSE in the morning trade.
-
Suven Life Gets Patent For Neuro-Degenerative Drug
With the new patents, Suven has a total of 20 granted patent from Eurasia and 6 from Norway.
-
Suven Life Surges On Getting Patent For Neuro Degenerative Drug
Shares of Suven Life Sciences rose over 5 per cent today as the company has been granted one product patent each by Europe and Israel for a drug used in the treatment of neuro-degenerative diseases.
-
Suven Gets 2 Patents For Molecules Targeting CNS Disorder
The products are useful in the treatment of cognitive impairment associated with neuro-degenerative disorders like Alzheimer's disease, attention-deficient hyperactivity disorder, Huntington's disease, major depressive disorder, Parkinson's and schizophrenia, Suven Life Sciences said.
-
Suven Life Receives Establishment Inspection Report From USFDA
Drug firm Suven Life Sciences said it has received the Establishment Inspection Report (EIR) from the US health regulator for its manufacturing plant near Hyderabad.
-
Suven Life Up Over 3% On Patent For Neuro-Degenerative Drug
Suven Life said it has been granted "one product patent from Europe and two product patents from Eurasia corresponding to New Chemical Entities (NCEs) for treatment of disorders associated with neuro-degenerative diseases".
-
Suven Life Gets Patents For Neuro-Degenerative Drug
Drug firm Suven Life Sciences has been granted a patent each by Australia, Eurasia, Israel and the US for a drug used in treatment of neuro-degenerative diseases.
-
Suven Life Gets Patent for Neuro-Degenerative Drug, Shares Rise
Suven Life Sciences has been granted a patent each by China, Eurasia and Hong Kong for a drug used in the treatment of neuro-degenerative diseases.
-
Suven Life Sciences Gets Patent Rights For 2 Drugs; Shares Rally 5%
Suven Life Sciences shares rallied as much as 5 per cent to hit intra-day high of Rs 275.20, after the company declared it had received patent rights from Europe and Macau for two drugs used in the treatment of disorders associated with neurodegenerative diseases.
-
Suven Life Gets Patent for Neuro-Degenerative Drug
Suven Life Sciences has been granted a patent each by Europe, Hong Kong, Japan, Macau, the African Regional Intellectual Property Organisationand South Korea for a drug used in the treatment of neuro-degenerative diseases.
-
Suven Life Sciences Gets Product Patents for CNS Molecule
Products out of these inventions may be out-licenced at various phases of clinical development like at Phase-I or Phase-II, Suven said.
-
Suven Life Gets Patents for Neurodegenerative Drug
Biopharma firm Suven Life Sciences on Wednesday said it has been granted two patents from Canada and one in China for a drug used in the treatment of neurodegenerative diseases.
-
Suven Life Gets Patent for Neuro-Degenerative Disease-Related Products
Drug firm Suven Life Sciences has been granted patents by China, South Africa and Mexico for new chemical molecules that can be used in drugs for treating neuro-degenerative diseases.
-
Suven Life Sciences allots equity shares
Under ESOPThe committee of Suven Life Sciences on 05 May 2010 has allotted 6,61,848 equity shares under stock option plans of the company.Further, consequent to the above allotment, the paid up share capital of the company has gone up from 115874400 equity shares of Re 1 each, aggregating to Rs. 11.59 crore to 116536248 equity shares of Re 1 each, ...
